CN Stock MarketDetailed Quotes

300753 Jiangsu Apon Medical Technology

Watchlist
  • 17.63
  • -1.17-6.22%
Market Closed Dec 31 15:00 CST
2.22BMarket Cap419.76P/E (TTM)

Jiangsu Apon Medical Technology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-7.12%274.75M
-4.89%179.47M
-6.71%87.75M
30.38%422.17M
37.99%295.81M
32.24%188.7M
29.22%94.07M
-29.79%323.81M
-33.88%214.38M
-33.26%142.69M
Operating revenue
-7.12%274.75M
-4.89%179.47M
-6.71%87.75M
30.38%422.17M
37.99%295.81M
32.24%188.7M
29.22%94.07M
-29.79%323.81M
-33.88%214.38M
-33.26%142.69M
Other operating revenue
----
-51.51%309.84K
----
222.31%1.38M
----
5.35%639.02K
----
-12.24%429.59K
----
110.13%606.59K
Total operating cost
-7.47%271.03M
-6.94%176.07M
-12.60%86.64M
1.36%415.6M
7.27%292.9M
11.42%189.2M
15.25%99.12M
-0.44%410.01M
-0.40%273.07M
-1.88%169.8M
Operating cost
-20.09%85.11M
-20.39%57.08M
-18.40%29.91M
-11.18%145.45M
12.11%106.52M
28.46%71.71M
19.08%36.66M
-1.55%163.76M
-17.33%95.01M
-25.48%55.82M
Operating tax surcharges
24.72%3.47M
1.44%1.93M
-15.20%911.64K
13.75%4.19M
16.27%2.78M
17.99%1.9M
36.93%1.08M
-11.34%3.68M
-19.93%2.39M
-19.03%1.61M
Operating expense
1.36%100.71M
1.57%59.74M
-21.09%24.77M
3.58%147.71M
11.20%99.35M
1.29%58.81M
20.72%31.38M
12.88%142.6M
33.09%89.35M
27.87%58.07M
Administration expense
3.97%57.43M
10.74%40.88M
14.80%22.77M
25.27%80.88M
2.80%55.24M
9.51%36.92M
10.45%19.84M
-12.04%64.56M
-19.20%53.73M
-15.63%33.71M
Financial expense
28.87%897.77K
135.54%697.45K
24.08%598.88K
82.60%825.48K
194.71%696.68K
148.63%296.11K
88.17%482.64K
118.99%452.06K
76.53%-735.57K
78.15%-608.93K
-Interest expense (Financial expense)
125.56%2.27M
9.40%680.83K
14.78%332.17K
24.18%3.07M
178.56%1.01M
352.23%622.35K
2,070.47%289.4K
118.92%2.47M
13.17%361.13K
-56.87%137.62K
-Interest Income (Financial expense)
13.88%-1.42M
37.62%-828.64K
25.59%-199.88K
-10.69%-2.31M
35.76%-1.65M
24.39%-1.33M
-14.61%-268.62K
42.24%-2.08M
34.58%-2.57M
46.11%-1.76M
Research and development
-17.33%23.41M
-19.55%15.74M
-20.75%7.68M
4.59%36.55M
-15.02%28.32M
-7.71%19.57M
-5.26%9.69M
-20.54%34.95M
29.35%33.32M
56.11%21.2M
Credit Impairment Loss
47.39%-3.11M
116.10%605.67K
128.01%1.64M
-710.58%-7.72M
-3.38%-5.91M
29.19%-3.76M
156.96%720.21K
85.87%-952.89K
-5.76%-5.72M
-52.94%-5.31M
Asset Impairment Loss
-454.99%-113.6K
501.32%192.42K
----
97.13%-470.73K
-63.23%32K
-63.23%32K
----
-18,745.44%-16.4M
--87.03K
--87.03K
Other net revenue
48.04%9.25M
75.65%11.97M
-61.77%2.99M
448.63%7.4M
51.04%6.25M
250.90%6.81M
769.44%7.82M
-133.18%-2.12M
8.85%4.14M
-17.98%1.94M
Invest income
22.91%-598.29K
-382.22%-535.15K
132.91%85.12K
-200.76%-1.44M
-157.16%-776.09K
235.97%189.62K
61.43%-258.61K
66.56%1.43M
59.68%-301.79K
88.22%-139.46K
-Including: Investment income associates
51.52%-689.71K
-120.53%-646.67K
-58.14%-408.95K
-45.74%-1.18M
-8.70%-1.42M
61.80%-293.24K
61.43%-258.61K
51.62%-812.75K
22.46%-1.31M
40.41%-767.6K
Asset deal income
54,641.94%3.64M
115,890.66%3.53M
----
133.04%6.66K
114.25%6.66K
106.51%3.04K
----
---20.15K
---46.71K
---46.71K
Other revenue
-26.90%9.43M
-20.97%8.18M
-82.84%1.26M
23.15%17.03M
27.48%12.9M
40.78%10.35M
159.69%7.36M
11.74%13.82M
1.62%10.12M
4.67%7.35M
Operating profit
41.66%12.97M
143.43%15.37M
48.33%4.11M
115.81%13.97M
116.79%9.16M
125.08%6.31M
122.49%2.77M
-258.32%-88.32M
-201.29%-54.55M
-158.38%-25.17M
Add:Non operating Income
-98.06%941.14
-93.25%565.37
-72.06%838.32
26.85%180.83K
-75.13%48.57K
-17.77%8.38K
-99.03%3K
-15.17%142.55K
3,791.44%195.28K
103.03%10.19K
Less:Non operating expense
679.61%2.48M
707.10%2.08M
1,832.87%2M
-86.61%338.54K
-70.65%317.69K
-73.75%257.55K
-81.33%103.61K
285.85%2.53M
211.77%1.08M
230.38%981.2K
Total profit
18.10%10.5M
119.16%13.29M
-21.10%2.11M
115.22%13.81M
116.04%8.89M
123.20%6.06M
121.25%2.67M
-264.03%-90.71M
-203.60%-55.43M
-161.04%-26.14M
Less:Income tax cost
343.35%6.63M
51.04%4.49M
-31.03%978.15K
136.72%5.36M
192.51%1.49M
509.65%2.97M
229.01%1.42M
-836.25%-14.59M
-132.07%-1.62M
-113.47%-725.83K
Net profit
-47.64%3.87M
184.70%8.8M
-9.83%1.13M
111.10%8.45M
113.74%7.4M
112.16%3.09M
110.91%1.25M
-242.76%-76.12M
-211.04%-53.82M
-167.89%-25.41M
Net profit from continuing operation
-47.64%3.87M
184.70%8.8M
-9.83%1.13M
111.10%8.45M
113.74%7.4M
112.16%3.09M
110.91%1.25M
-242.76%-76.12M
-211.04%-53.82M
-167.89%-25.41M
Less:Minority Profit
-89.19%64.59K
-129.76%-95.89K
-762.56%-229.65K
227.31%172.7K
137.68%597.54K
131.44%322.22K
107.33%34.66K
81.80%-135.66K
-6,297.58%-1.59M
-516.31%-1.02M
Net profit of parent company owners
-43.99%3.81M
221.31%8.89M
11.63%1.36M
110.89%8.28M
113.01%6.8M
111.35%2.77M
111.06%1.22M
-240.54%-75.98M
-207.82%-52.23M
-165.58%-24.39M
Earning per share
Basic earning per share
-43.97%0.0302
220.91%0.0706
12.50%0.0108
110.90%0.0657
113.01%0.0539
111.37%0.022
111.01%0.0096
-240.55%-0.6028
-207.83%-0.4144
-165.59%-0.1935
Diluted earning per share
-43.97%0.0302
220.91%0.0706
12.50%0.0108
110.90%0.0657
113.01%0.0539
111.37%0.022
111.01%0.0096
-240.55%-0.6028
-207.83%-0.4144
-165.59%-0.1935
Other composite income
Total composite income
-47.64%3.87M
184.70%8.8M
-9.83%1.13M
111.10%8.45M
113.74%7.4M
112.16%3.09M
110.91%1.25M
-242.76%-76.12M
-211.04%-53.82M
-167.89%-25.41M
Total composite income of parent company owners
-43.99%3.81M
221.31%8.89M
11.63%1.36M
110.89%8.28M
113.01%6.8M
111.35%2.77M
111.06%1.22M
-240.54%-75.98M
-207.82%-52.23M
-165.58%-24.39M
Total composite income of minority owners
-89.19%64.59K
-129.76%-95.89K
-762.56%-229.65K
227.31%172.7K
137.68%597.54K
131.44%322.22K
107.33%34.66K
81.80%-135.66K
-6,297.58%-1.59M
-516.31%-1.02M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Total operating revenue -7.12%274.75M -4.89%179.47M -6.71%87.75M 30.38%422.17M 37.99%295.81M 32.24%188.7M 29.22%94.07M -29.79%323.81M -33.88%214.38M -33.26%142.69M
Operating revenue -7.12%274.75M -4.89%179.47M -6.71%87.75M 30.38%422.17M 37.99%295.81M 32.24%188.7M 29.22%94.07M -29.79%323.81M -33.88%214.38M -33.26%142.69M
Other operating revenue ---- -51.51%309.84K ---- 222.31%1.38M ---- 5.35%639.02K ---- -12.24%429.59K ---- 110.13%606.59K
Total operating cost -7.47%271.03M -6.94%176.07M -12.60%86.64M 1.36%415.6M 7.27%292.9M 11.42%189.2M 15.25%99.12M -0.44%410.01M -0.40%273.07M -1.88%169.8M
Operating cost -20.09%85.11M -20.39%57.08M -18.40%29.91M -11.18%145.45M 12.11%106.52M 28.46%71.71M 19.08%36.66M -1.55%163.76M -17.33%95.01M -25.48%55.82M
Operating tax surcharges 24.72%3.47M 1.44%1.93M -15.20%911.64K 13.75%4.19M 16.27%2.78M 17.99%1.9M 36.93%1.08M -11.34%3.68M -19.93%2.39M -19.03%1.61M
Operating expense 1.36%100.71M 1.57%59.74M -21.09%24.77M 3.58%147.71M 11.20%99.35M 1.29%58.81M 20.72%31.38M 12.88%142.6M 33.09%89.35M 27.87%58.07M
Administration expense 3.97%57.43M 10.74%40.88M 14.80%22.77M 25.27%80.88M 2.80%55.24M 9.51%36.92M 10.45%19.84M -12.04%64.56M -19.20%53.73M -15.63%33.71M
Financial expense 28.87%897.77K 135.54%697.45K 24.08%598.88K 82.60%825.48K 194.71%696.68K 148.63%296.11K 88.17%482.64K 118.99%452.06K 76.53%-735.57K 78.15%-608.93K
-Interest expense (Financial expense) 125.56%2.27M 9.40%680.83K 14.78%332.17K 24.18%3.07M 178.56%1.01M 352.23%622.35K 2,070.47%289.4K 118.92%2.47M 13.17%361.13K -56.87%137.62K
-Interest Income (Financial expense) 13.88%-1.42M 37.62%-828.64K 25.59%-199.88K -10.69%-2.31M 35.76%-1.65M 24.39%-1.33M -14.61%-268.62K 42.24%-2.08M 34.58%-2.57M 46.11%-1.76M
Research and development -17.33%23.41M -19.55%15.74M -20.75%7.68M 4.59%36.55M -15.02%28.32M -7.71%19.57M -5.26%9.69M -20.54%34.95M 29.35%33.32M 56.11%21.2M
Credit Impairment Loss 47.39%-3.11M 116.10%605.67K 128.01%1.64M -710.58%-7.72M -3.38%-5.91M 29.19%-3.76M 156.96%720.21K 85.87%-952.89K -5.76%-5.72M -52.94%-5.31M
Asset Impairment Loss -454.99%-113.6K 501.32%192.42K ---- 97.13%-470.73K -63.23%32K -63.23%32K ---- -18,745.44%-16.4M --87.03K --87.03K
Other net revenue 48.04%9.25M 75.65%11.97M -61.77%2.99M 448.63%7.4M 51.04%6.25M 250.90%6.81M 769.44%7.82M -133.18%-2.12M 8.85%4.14M -17.98%1.94M
Invest income 22.91%-598.29K -382.22%-535.15K 132.91%85.12K -200.76%-1.44M -157.16%-776.09K 235.97%189.62K 61.43%-258.61K 66.56%1.43M 59.68%-301.79K 88.22%-139.46K
-Including: Investment income associates 51.52%-689.71K -120.53%-646.67K -58.14%-408.95K -45.74%-1.18M -8.70%-1.42M 61.80%-293.24K 61.43%-258.61K 51.62%-812.75K 22.46%-1.31M 40.41%-767.6K
Asset deal income 54,641.94%3.64M 115,890.66%3.53M ---- 133.04%6.66K 114.25%6.66K 106.51%3.04K ---- ---20.15K ---46.71K ---46.71K
Other revenue -26.90%9.43M -20.97%8.18M -82.84%1.26M 23.15%17.03M 27.48%12.9M 40.78%10.35M 159.69%7.36M 11.74%13.82M 1.62%10.12M 4.67%7.35M
Operating profit 41.66%12.97M 143.43%15.37M 48.33%4.11M 115.81%13.97M 116.79%9.16M 125.08%6.31M 122.49%2.77M -258.32%-88.32M -201.29%-54.55M -158.38%-25.17M
Add:Non operating Income -98.06%941.14 -93.25%565.37 -72.06%838.32 26.85%180.83K -75.13%48.57K -17.77%8.38K -99.03%3K -15.17%142.55K 3,791.44%195.28K 103.03%10.19K
Less:Non operating expense 679.61%2.48M 707.10%2.08M 1,832.87%2M -86.61%338.54K -70.65%317.69K -73.75%257.55K -81.33%103.61K 285.85%2.53M 211.77%1.08M 230.38%981.2K
Total profit 18.10%10.5M 119.16%13.29M -21.10%2.11M 115.22%13.81M 116.04%8.89M 123.20%6.06M 121.25%2.67M -264.03%-90.71M -203.60%-55.43M -161.04%-26.14M
Less:Income tax cost 343.35%6.63M 51.04%4.49M -31.03%978.15K 136.72%5.36M 192.51%1.49M 509.65%2.97M 229.01%1.42M -836.25%-14.59M -132.07%-1.62M -113.47%-725.83K
Net profit -47.64%3.87M 184.70%8.8M -9.83%1.13M 111.10%8.45M 113.74%7.4M 112.16%3.09M 110.91%1.25M -242.76%-76.12M -211.04%-53.82M -167.89%-25.41M
Net profit from continuing operation -47.64%3.87M 184.70%8.8M -9.83%1.13M 111.10%8.45M 113.74%7.4M 112.16%3.09M 110.91%1.25M -242.76%-76.12M -211.04%-53.82M -167.89%-25.41M
Less:Minority Profit -89.19%64.59K -129.76%-95.89K -762.56%-229.65K 227.31%172.7K 137.68%597.54K 131.44%322.22K 107.33%34.66K 81.80%-135.66K -6,297.58%-1.59M -516.31%-1.02M
Net profit of parent company owners -43.99%3.81M 221.31%8.89M 11.63%1.36M 110.89%8.28M 113.01%6.8M 111.35%2.77M 111.06%1.22M -240.54%-75.98M -207.82%-52.23M -165.58%-24.39M
Earning per share
Basic earning per share -43.97%0.0302 220.91%0.0706 12.50%0.0108 110.90%0.0657 113.01%0.0539 111.37%0.022 111.01%0.0096 -240.55%-0.6028 -207.83%-0.4144 -165.59%-0.1935
Diluted earning per share -43.97%0.0302 220.91%0.0706 12.50%0.0108 110.90%0.0657 113.01%0.0539 111.37%0.022 111.01%0.0096 -240.55%-0.6028 -207.83%-0.4144 -165.59%-0.1935
Other composite income
Total composite income -47.64%3.87M 184.70%8.8M -9.83%1.13M 111.10%8.45M 113.74%7.4M 112.16%3.09M 110.91%1.25M -242.76%-76.12M -211.04%-53.82M -167.89%-25.41M
Total composite income of parent company owners -43.99%3.81M 221.31%8.89M 11.63%1.36M 110.89%8.28M 113.01%6.8M 111.35%2.77M 111.06%1.22M -240.54%-75.98M -207.82%-52.23M -165.58%-24.39M
Total composite income of minority owners -89.19%64.59K -129.76%-95.89K -762.56%-229.65K 227.31%172.7K 137.68%597.54K 131.44%322.22K 107.33%34.66K 81.80%-135.66K -6,297.58%-1.59M -516.31%-1.02M
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified opinion -- -- -- Unqualified opinion -- --
Auditor -- -- -- Tianjian Certified Public Accountants (Special General Partnership) -- -- -- Tianjian Certified Public Accountants (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.